Because Heart Matters!

Welcome to Klavant – precision in healthcare

Revolutionizing Cardiac Surgery with AI-Powered Innovation

At Klavant, we envision a future where heart surgeons are equipped with advanced tools that ensure the performance and long-term durability of the natural aortic valve (AV) geometry, while also eliminating the need for re-operations. Our goal is to improve quality of life worldwide by transforming surgical outcomes.

Our mission is to lead innovations in surgical technology by developing and implementing cutting-edge digital intraoperative quality control systems and AI-based image-assisting solutions. We are committed to enhancing the assessment of aortic valve competence during surgical aortic valve repair (SAVR) and aorta ascendens resections. By providing surgeons with the insights and technology they need, we aim to revolutionize heart surgery and contribute to better healthcare outcomes across the globe.


The Challenge in Cardiac Surgery

Millions suffer from severe heart disease, and for over 400.000 patients each year, TAVI isn’t an option due to age, co-morbidities or long-term considerations. For them, traditional open-heart surgery remains the only solution, requiring:

  • Opening the chest and stopping the heart
  • Using a heart-lung machine
  • Precise repair or replacement of the valve

The Problem: Outdated Tools in High-Tech Environments

Even in state-of-the-art operating rooms, surgeons face challenges when assessing valve function under non-natural conditions. Traditional tools like rulers and saline tests, though reliable, lack the precision required for today’s complex surgeries, leading to:

  • Longer surgery times
  • Risk of reoperations

The Solution: AI-Powered Precision by Klavant

Klavant transforms cardiac surgery with AI-driven tools that enhance precision and decision-making. Our goal is to enable surgeons to:

  • Accurately measure valve competence with natural pressure conditions
  • Visualize structures in real-time with exceptional clarity
  • Make data-driven decisions that improve outcomes and reduce risks

By integrating AI and advanced imaging, Klavant empowers surgeons to perform with even greater precision, ensuring better outcomes for patients.


Our Status

Klavant is an innovative MedTech company in the pre-clinical stage, focused on developing AI-powered solutions for cardiac surgery. Our AI-driven tools aim to provide heart surgeons with insights, enhancing precision during valve repair and replacement procedures. These solutions are designed to improve decision-making, reduce risks and optimize surgical outcomes.

Our Goal

Klavant is revolutionizing cardiac surgery with AI-powered tools that enhance precision and decision-making. Our technology equips surgeons with advanced capabilities for more accurate measurements, better visualization and data-driven support, offering significant benefits such as:

  • Faster surgeries: reducing time spent on critical procedures, improving patient safety and outcomes
  • Preventing re-operation: improved surgical outcome plus aortic valve competence will decrease re-operation
  • Cost savings for healthcare systems: minimizing complications and improving efficiency, leading to optimized resource use and less post-operative treatment costs
  • Decrease lifelong medication: necessary medication for patient due to aortic valve insufficiency and side effects can be reduced

Through these innovations, Klavant aims to improve patient outcomes, reduce reoperation rates and redefine the standard of care in heart valve surgery.


10/24 – Klavant joins the prestigious Creative Destruction Lab Berlin program, paving the way for exciting advancements in healthcare innovation.


10/23 – We are excited to share our latest press release, which marks an important milestone. 

innovative and digital

artificial intelligence

performance measurement

20.11.2020

Klavant is winner of ideas phase at Science4Life Venture Cup!

In the highly renowned Germany-wide Science4Life competition, which has been held for over 20 years, Klavant was awarded winner of the ideas phase in the Life Science Venture Cup category among around 60 participants.

17.11.2020

1st place in the MedTech Business Plan 2020 competition

Klavant won the prestigious German medical technology business plan competition 2020 among approx. 50 applicants and 11 finalists. The participants qualified for the finals in a multi-stage process over half a year. Around 60 experts were involved in evaluating the participating startups.

28.10.2020

2nd place at VENTURE.Med 2020 competition

At the hybrid startup pitching competition VENTURE.Med 2020 organized by Business Angel Network Germany and the initiatives ProRuhrgebiet and Digital Economy of NRW, Klavant won the 2nd place. From around 60 participants, the 30-person screening committee selected the TOP 10 as finalists, who were able to present their business ideas in Cologne. Klavant convinced both the expert panel on site and the more than 100 investors who took part in the event online and who were able to vote for their favorites.

Interested in clinical partnerships or receiving our abstract?

Please contact us:
info(at)klavant.de
Phone: +49 (0) 571 / 783 419 – 0